PL1824450T3 - Kompozycje do podawania donosowego - Google Patents

Kompozycje do podawania donosowego

Info

Publication number
PL1824450T3
PL1824450T3 PL05791723T PL05791723T PL1824450T3 PL 1824450 T3 PL1824450 T3 PL 1824450T3 PL 05791723 T PL05791723 T PL 05791723T PL 05791723 T PL05791723 T PL 05791723T PL 1824450 T3 PL1824450 T3 PL 1824450T3
Authority
PL
Poland
Prior art keywords
compositions
intranasal administration
intranasal
administration
Prior art date
Application number
PL05791723T
Other languages
English (en)
Inventor
Michael James
Peter Josling
Original Assignee
Nasaleze Patents Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0422582A external-priority patent/GB0422582D0/en
Priority claimed from JP2005209097A external-priority patent/JP2007022971A/ja
Priority claimed from GB0519213A external-priority patent/GB2420707A/en
Application filed by Nasaleze Patents Ltd filed Critical Nasaleze Patents Ltd
Publication of PL1824450T3 publication Critical patent/PL1824450T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL05791723T 2004-10-11 2005-10-10 Kompozycje do podawania donosowego PL1824450T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0422582A GB0422582D0 (en) 2004-10-11 2004-10-11 Pharmaceutical compositions
GB0502792A GB2419528A (en) 2004-10-11 2005-02-10 Cellulose powder and signalling agent composition suitable for nasal administration
JP2005209097A JP2007022971A (ja) 2005-07-19 2005-07-19 経鼻投与のための組成物
GB0519213A GB2420707A (en) 2004-10-11 2005-09-21 Compositions for intranasal administration
PCT/GB2005/050179 WO2006040596A2 (en) 2004-10-11 2005-10-10 Compositions for intranasal administration
EP05791723A EP1824450B1 (en) 2004-10-11 2005-10-10 Compositions for intranasal administration

Publications (1)

Publication Number Publication Date
PL1824450T3 true PL1824450T3 (pl) 2013-04-30

Family

ID=36010898

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05791723T PL1824450T3 (pl) 2004-10-11 2005-10-10 Kompozycje do podawania donosowego

Country Status (5)

Country Link
EP (1) EP1824450B1 (pl)
JP (1) JP5254618B2 (pl)
CA (1) CA2583794C (pl)
PL (1) PL1824450T3 (pl)
WO (1) WO2006040596A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US9770047B2 (en) * 2008-04-10 2017-09-26 U.S. Nutraceuticals, LLC Perilla seed composition
US9610313B2 (en) 2008-04-10 2017-04-04 U.S. Nutraceuticals Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids
GB201410250D0 (en) * 2014-06-10 2014-07-23 Nasaleze Patents Ltd Improvements to nasal compositions and method of use thereof
CA2923767A1 (en) 2016-03-14 2017-09-14 Timothy R. St. Germain Method of using n-hydroxy-1,4-napthalenedione as a novel herbicide
CN109640947A (zh) * 2016-08-05 2019-04-16 株式会社新日本科学 鼻内药物粉末组合物
US20180221426A1 (en) * 2017-02-06 2018-08-09 William Van Dover Stoecker Compositions and Methods for Treating and Removing Seborrheic Keratoses
CN106821980B (zh) * 2017-02-17 2019-10-18 成都博创必成生物技术有限公司 一种鼻腔喷雾剂及其制备方法和生物阻隔膜
CN106890197B (zh) * 2017-04-11 2018-07-31 成都益植生物科技有限公司 一种定植益生菌制剂及其应用和药物
EP3960194B1 (de) * 2020-09-01 2024-03-20 Volker Loos Zusammensetzung zur verminderung der symptome der nykturie
GB202205769D0 (en) * 2022-04-20 2022-06-01 Nasaleze Patents Ltd Compositions and applications therefor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
DK49791D0 (da) * 1991-03-20 1991-03-20 Novo Nordisk As Nasalt pulverpraeparat
AU660824B2 (en) * 1992-06-12 1995-07-06 Teijin Limited Pharmaceutical preparation for intra-airway administration
JP3098401B2 (ja) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JPH09227373A (ja) * 1996-02-21 1997-09-02 Teijin Ltd 抗インフルエンザウイルス剤
ATE247456T1 (de) * 1996-02-27 2003-09-15 Teijin Ltd Puderförmige zusammensetzung zur nasalen anwendung
CN1180839C (zh) * 1998-07-08 2004-12-22 麒麟-安姆根有限公司 用于粘膜给药的含有聚合物药物的粉末制剂
JP4632499B2 (ja) * 1999-08-26 2011-02-16 武田薬品工業株式会社 鼻粘膜付着マトリックス
JP2004018491A (ja) * 2002-06-19 2004-01-22 Taisho Pharmaceut Co Ltd プロスタグランジン含有経鼻投与製剤組成物
WO2004078211A1 (ja) * 2003-03-04 2004-09-16 Tanabe Seiyaku Co., Ltd. 粉末経鼻投与製剤

Also Published As

Publication number Publication date
JP2008515870A (ja) 2008-05-15
WO2006040596A2 (en) 2006-04-20
JP5254618B2 (ja) 2013-08-07
WO2006040596A3 (en) 2006-06-01
CA2583794A1 (en) 2006-04-20
CA2583794C (en) 2015-05-26
EP1824450B1 (en) 2012-11-14
EP1824450A2 (en) 2007-08-29

Similar Documents

Publication Publication Date Title
EP1718714A4 (en) COMPOSITIONS CONTAINING A PLOTTER
IL223545A0 (en) Pharmaceutical compositions
ZA200700030B (en) Pharmaceutical compositions
PL1824450T3 (pl) Kompozycje do podawania donosowego
GB0408308D0 (en) Pharmaceutical compositions
ZA200904425B (en) Nemathical compositions
PL1837019T3 (pl) Kompozycja farmaceutyczna rozpadająca się w ustach
GB0405406D0 (en) Anti-vaginitis compositions
GB0405033D0 (en) Novel pharmaceutical compositions
EP1805154A4 (en) PHARMACEUTICAL COMPOSITIONS
ZA200701197B (en) Compositions
GB0410140D0 (en) Compositions
GB0519213D0 (en) Compositions for intranasal administration
EP1747205A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0502792D0 (en) Pharmaceutical compositions
GB0515212D0 (en) Compositions for intranasal administration
GB0420627D0 (en) Monoglyceride-containing compositions
GB0425445D0 (en) Novel compositions
ZA200704633B (en) Anthelmintic compositions
GB0411502D0 (en) Pharmaceutical compositions
GB0407351D0 (en) Pharmaceutical compositions
GB0400971D0 (en) Pharmaceutical compositions
GB0412039D0 (en) Compositions
GB0412304D0 (en) Compositions
GB0401515D0 (en) Compositions